Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H

As of June 30, 2024, Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H carries a market capitalization of 733.93M, placing it among publicly traded companies globally. Its enterprise value stands at 130.14M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2024, Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H has 560.25M shares outstanding.

These figures are as of June 30, 2024.

As of June 30, 2024, Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H maintains a current ratio of 1.74, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2024.

Over the twelve months ended June 30, 2024, Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H recorded 37.93M in income tax expense.

As of the close on October 22, 2026, Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H's stock has gained approximately 14.68% over the past 52 weeks. The 50-day moving average sits at 2.35, while the 200-day moving average is 2.28.

As of June 30, 2024, Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H holds 693.77M in cash and equivalents against 89.99M in total debt, resulting in a net debt position of -277.72M. Total book value stands at 1.70B, with working capital of 532.80M providing operational flexibility.